We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+9.78%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$258B
AUM Growth
+$11.2B
(+4.5%)
Cap. Flow
-$8.74B
Cap. Flow
% of AUM
-3.39%
Top 10 Holdings %
Top 10 Hldgs %
19.2%
Holding
3,329
New
40
Increased
1,011
Reduced
1,986
Closed
159
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Prologis
PLD
|
+$352M |
| 2 |
Merck
MRK
|
+$333M |
| 3 |
NVIDIA
NVDA
|
+$306M |
| 4 |
Atlassian
TEAM
|
+$280M |
| 5 |
Corteva
CTVA
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.41B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$331M |
| 3 |
iShares Russell 1000 Growth ETF
IWF
|
+$266M |
| 4 |
Danaher
DHR
|
+$240M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.56% |
| 2 | Healthcare | 14.16% |
| 3 | Financials | 12.95% |
| 4 | Consumer Discretionary | 9.76% |
| 5 | Industrials | 9.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2176
Artivion
AORT
$1.32B
| $2.9M | ﹤0.01% |
239,022
+115,462
| +93% | +$1.39M |
|
2177
PDF Solutions
PDFS
$2.07B
| $2.89M | ﹤0.01% |
101,476
-3,762
| -4% | -$102K |
|
2178
CryoPort
CYRX
$762M
| $2.88M | ﹤0.01% |
166,258
-6,024
| -3% | -$127K |
|
2179
Orthofix Medical
OFIX
$419M
| $2.88M | ﹤0.01% |
140,416
+873
| +0.6% | +$15.4K |
|
2180
Apogee Enterprises
APOG
$908M
| $2.88M | ﹤0.01% |
64,801
-2,482
| -4% | -$112K |
|
|
PTVE
2181
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
| $2.87M | ﹤0.01% |
252,738
+24,040
| +11% | +$262K |
|
|
NVEI
2182
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $2.87M | ﹤0.01% |
115,481
| – | – |
|
2183
Smith & Wesson
SWBI
$637M
| $2.87M | ﹤0.01% |
330,388
-27,002
| -8% | -$284K |
|
2184
4D Molecular Therapeutics
FDMT
$562M
| $2.87M | ﹤0.01% |
129,097
-17,104
| -12% | -$264K |
|
2185
Veru
VERU
$37.4M
| $2.87M | ﹤0.01% |
54,266
+18,887
| +53% | +$1.56M |
|
|
FTCH
2186
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $2.87M | ﹤0.01% |
605,568
-117,967
| -16% | -$822K |
|
2187
Sana Biotechnology
SANA
$980M
| $2.86M | ﹤0.01% |
724,625
+287,018
| +66% | +$1.4M |
|
2188
Enanta Pharmaceuticals
ENTA
$400M
| $2.86M | ﹤0.01% |
61,380
-9,095
| -13% | -$415K |
|
|
AMBR
2189
Amber International Holding Ltd
AMBR
$130M
| $2.86M | ﹤0.01% |
741,766
-19,459
| -3% | -$59.2K |
|
2190
Nicolet Bankshares
NIC
$3.62B
| $2.84M | ﹤0.01% |
35,642
-6,186
| -15% | -$482K |
|
2191
Theravance Biopharma
TBPH
$877M
| $2.83M | ﹤0.01% |
252,047
+75,874
| +43% | +$797K |
|
2192
Teekay
TK
$985M
| $2.83M | ﹤0.01% |
622,500
+320,131
| +106% | +$1.33M |
|
|
NUTX
2193
Nutex Health
NUTX
$1.11B
| $2.82M | ﹤0.01% |
9,883
+9,052
| +1,089% | +$1.74M |
|
2194
Liberty Media Series A
FWONA
$23.6B
| $2.81M | ﹤0.01% |
55,006
+217
| +0.4% | +$11K |
|
2195
Levi Strauss
LEVI
$9.39B
| $2.8M | ﹤0.01% |
180,358
-724
| -0.4% | -$11.2K |
|
|
TA
2196
DELISTED
TravelCenters of America LLC
TA
| $2.79M | ﹤0.01% |
62,409
-21,776
| -26% | -$1.13M |
|
2197
Fastly Inc
FSLY
$3.66B
| $2.79M | ﹤0.01% |
340,531
-45,727
| -12% | -$401K |
|
|
DAWN
2198
DELISTED
Day One Biopharmaceuticals
DAWN
| $2.79M | ﹤0.01% |
421,127
-27,643
| -6% | -$567K |
|
|
TCS
2199
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $2.79M | ﹤0.01% |
43,104
+15,702
| +57% | +$1.14M |
|
|
CUTR
2200
DELISTED
Cutera, Inc.
CUTR
| $2.79M | ﹤0.01% |
62,970
-2,472
| -4% | -$113K |
|
Similar funds
VFT
Nuveen's Q4 2022 Portfolio in Review
As of Q4 2022, Nuveen held 3,329 positions worth $258B, up 4.5% from $247B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Nuveen withdrew a net $8.74B in Q4 2022, closing 159 positions and reducing 1,986 holdings. Its most notable exit was Twitter, Inc., an estimated $237M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Nuveen opened a new position in Atlassian worth $226M.
- Nuveen's largest Q4 2022 buy was Atlassian: 1,759,716 shares worth $226M.
- Nuveen added most to Prologis in Q4 2022, an estimated $352M increase.
- Nuveen's biggest Q4 2022 reduction was Alnylam Pharmaceuticals, cutting an estimated $3.41B.
- Nuveen fully exited Twitter, Inc. in Q4 2022, selling an estimated $237M.
- Nuveen's ten largest holdings make up 19% of its $258B portfolio in Q4 2022.
- Nuveen opened 40 new positions and closed 159 in Q4 2022.
- Nuveen's portfolio value rose 4.5% quarter-over-quarter to $258B.
Based on Nuveen's 13F filing for Q4 2022, filed 14 Feb 2023.